“Last resort” myeloma treatment approved

The US FDA has granted accelerated approval to XPOVIO for the treatment of resistant or relapsed multiple myeloma. XPOVIO (Selinexor) was developed by Karyopharm Therapeutics, established by Israel’s Dr. Sharon Shacham,.and based in Newton MA.




This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *